Stock Events

Stock Events

Metagenomi Therapeutics (MGX) Q4 2025 Earnings

11NovConfirmed

Q1 2025

Q2 2025

Q3 2025

Q4 2025

-0.75

-0.62

-0.5

-0.37

Details

Expected EPS

-0.58448

Actual EPS

-0.55

Surprise EPS

0.03

Surprise Percent

+5.9%

Description

Metagenomi Therapeutics (MGX) has reported earnings of -0.55 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.